Advanced Glycation End Products Market
Global advanced glycation end products market growth is driven by increasing prevalence of diabetes and hypertension coupled with rising geriatric population worldwide. AGEs are molecules formed internally in the body as a result of non-enzymatic reactions between reducing sugars or carbohydrates and proteins or lipids. Accumulation of AGEs in the body causes damage by increasing oxidative stress and inflammation which can increase the risk of various chronic diseases. Due to growing health awareness, more research studies focusing on developing innovative AGE inhibition therapies can boost demand for AGE measurement tools and drugs to manage age-related conditions effectively.
Market Dynamics:
Global advanced glycation end products market growth is driven by factors like rising cases of diabetes and other lifestyle-related disorders, increasing aging population susceptible to chronic diseases, growing healthcare expenditure in developing nations, and ongoing research efforts to develop more effective AGE inhibitors. However, high costs associated with AGE detection technologies and lack of awareness can hamper the market growth. Developing low-cost point-of-care AGE measurement devices, establishing collaboration with research institutes, and expanding to emerging regions can offer opportunities for market players.
Key Features of the Study:
This report provides in-depth analysis of the global advanced glycation end products market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2024–2031), considering 2023 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global advanced glycation end products market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Keryx Biopharmaceuticals Inc., Alnylam Pharmaceuticals Inc., Amrax Bio, and others
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- Global advanced glycation end products market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global advanced glycation end products market
Detailed Segmentation-
Table of Contents
*Browse 32 market data tables and 28 figures on “Advanced Glycation End Products Market” - Global forecast to 2031
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now
Credibility and Certifications
860519526
9001:2015
27001:2022
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients
